ID

31247

Beschreibung

Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00871845

Link

https://clinicaltrials.gov/show/NCT00871845

Stichworte

Versionen (1)
  1. 02.08.18 02.08.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

2. August 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Obesity NCT00871845

Englisch

Eligibility Obesity NCT00871845

1 Formulare  
  1. StudyEvent: Eligibility
    1. Eligibility Obesity NCT00871845
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
18 years or older
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
positive diagnosis of hepatitis c, by polymerase chain reaction (pcr
Beschreibung

Hepatitis C Polymerase Chain Reaction

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0019196
UMLS CUI [1,2]
C0032520
scheduled to start treatment of hepatitis c by peg interferon and ribavirin
Beschreibung

Scheduled treatment Hepatitis C | PEG-interferon alfa | Ribavirin

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3844437
UMLS CUI [1,2]
C0019196
UMLS CUI [2]
C0907160
UMLS CUI [3]
C0035525
agreeing to give a written consent to participate in this study.
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients under 18 years of age
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
refusal to give a consent to participate in the study
Beschreibung

Informed Consent Refused

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1705116
history of recreational drug or alcohol use in the preceding 6 months
Beschreibung

Alcohol or Other Drugs use

Datentyp

boolean

Alias
UMLS CUI [1]
C0237123
pregnancy by hcg pregnancy testing which will be done prior to and monthly during the 12 month hepatitis c therapy and for 6 months following the end of treatment
Beschreibung

Pregnancy HCG pregnancy test

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0546577
plan for pregnancy during the study period
Beschreibung

Pregnancy, Planned

Datentyp

boolean

Alias
UMLS CUI [1]
C0032992
failure to adhere to contraceptive methods
Beschreibung

Contraceptive methods Adherence failed

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C1510802
UMLS CUI [1,3]
C0231175
hiv disease
Beschreibung

HIV Infection

Datentyp

boolean

Alias
UMLS CUI [1]
C0019693
evidence of cirrhosis or confirmed hepatocellular carcinoma (hcc), evidence of decompensated liver disease or presence of other liver diseases such as hepatitis b, hemochromatosis, autoimmune hepatitis and wilson disease
Beschreibung

Liver Cirrhosis | Liver carcinoma | Decompensated Liver Disease | Liver diseases | Hepatitis B | Hemochromatosis | Hepatitis, Autoimmune | Hepatolenticular Degeneration

Datentyp

boolean

Alias
UMLS CUI [1]
C0023890
UMLS CUI [2]
C2239176
UMLS CUI [3]
C0745744
UMLS CUI [4]
C0023895
UMLS CUI [5]
C0019163
UMLS CUI [6]
C0018995
UMLS CUI [7]
C0241910
UMLS CUI [8]
C0019202
patients will be removed from the study if they develop severe side effects to ifn (e.g marked depression, autoimmune reactions like thyroiditis, aplastic anemia..), severe side effects to ribavirin (e.g. marked hemolysis) or intolerance of orlistat/placebo (e.g. allergic reaction, diarrhea, flatulence..) and withdrawal of the consent.
Beschreibung

Adverse effects Severe Interferon | Depressive disorder Marked | Autoimmune reaction | Thyroiditis | Aplastic Anemia | Adverse effects Severe Ribavirin | Hemolysis Marked | Intolerance to Orlistat | Intolerance to placebo | Allergic Reaction | Diarrhea | Flatulence | Informed Consent Withdrawal

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0879626
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0021747
UMLS CUI [2,1]
C0011581
UMLS CUI [2,2]
C1706089
UMLS CUI [3]
C0443146
UMLS CUI [4]
C0040147
UMLS CUI [5]
C0002874
UMLS CUI [6,1]
C0879626
UMLS CUI [6,2]
C0205082
UMLS CUI [6,3]
C0035525
UMLS CUI [7,1]
C0019054
UMLS CUI [7,2]
C1706089
UMLS CUI [8,1]
C1744706
UMLS CUI [8,2]
C0076275
UMLS CUI [9,1]
C1744706
UMLS CUI [9,2]
C1696465
UMLS CUI [10]
C1527304
UMLS CUI [11]
C0011991
UMLS CUI [12]
C0016204
UMLS CUI [13,1]
C0021430
UMLS CUI [13,2]
C2349954
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Obesity NCT00871845

1 Formulare
  1. StudyEvent: Eligibility
    1. Eligibility Obesity NCT00871845
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
18 years or older
boolean
C0001779 (UMLS CUI [1])
Hepatitis C Polymerase Chain Reaction
Item
positive diagnosis of hepatitis c, by polymerase chain reaction (pcr
boolean
C0019196 (UMLS CUI [1,1])
C0032520 (UMLS CUI [1,2])
Scheduled treatment Hepatitis C | PEG-interferon alfa | Ribavirin
Item
scheduled to start treatment of hepatitis c by peg interferon and ribavirin
boolean
C3844437 (UMLS CUI [1,1])
C0019196 (UMLS CUI [1,2])
C0907160 (UMLS CUI [2])
C0035525 (UMLS CUI [3])
Informed Consent
Item
agreeing to give a written consent to participate in this study.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Age
Item
patients under 18 years of age
boolean
C0001779 (UMLS CUI [1])
Informed Consent Refused
Item
refusal to give a consent to participate in the study
boolean
C0021430 (UMLS CUI [1,1])
C1705116 (UMLS CUI [1,2])
Alcohol or Other Drugs use
Item
history of recreational drug or alcohol use in the preceding 6 months
boolean
C0237123 (UMLS CUI [1])
Pregnancy HCG pregnancy test
Item
pregnancy by hcg pregnancy testing which will be done prior to and monthly during the 12 month hepatitis c therapy and for 6 months following the end of treatment
boolean
C0032961 (UMLS CUI [1,1])
C0546577 (UMLS CUI [1,2])
Pregnancy, Planned
Item
plan for pregnancy during the study period
boolean
C0032992 (UMLS CUI [1])
Contraceptive methods Adherence failed
Item
failure to adhere to contraceptive methods
boolean
C0700589 (UMLS CUI [1,1])
C1510802 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
HIV Infection
Item
hiv disease
boolean
C0019693 (UMLS CUI [1])
Liver Cirrhosis | Liver carcinoma | Decompensated Liver Disease | Liver diseases | Hepatitis B | Hemochromatosis | Hepatitis, Autoimmune | Hepatolenticular Degeneration
Item
evidence of cirrhosis or confirmed hepatocellular carcinoma (hcc), evidence of decompensated liver disease or presence of other liver diseases such as hepatitis b, hemochromatosis, autoimmune hepatitis and wilson disease
boolean
C0023890 (UMLS CUI [1])
C2239176 (UMLS CUI [2])
C0745744 (UMLS CUI [3])
C0023895 (UMLS CUI [4])
C0019163 (UMLS CUI [5])
C0018995 (UMLS CUI [6])
C0241910 (UMLS CUI [7])
C0019202 (UMLS CUI [8])
Adverse effects Severe Interferon | Depressive disorder Marked | Autoimmune reaction | Thyroiditis | Aplastic Anemia | Adverse effects Severe Ribavirin | Hemolysis Marked | Intolerance to Orlistat | Intolerance to placebo | Allergic Reaction | Diarrhea | Flatulence | Informed Consent Withdrawal
Item
patients will be removed from the study if they develop severe side effects to ifn (e.g marked depression, autoimmune reactions like thyroiditis, aplastic anemia..), severe side effects to ribavirin (e.g. marked hemolysis) or intolerance of orlistat/placebo (e.g. allergic reaction, diarrhea, flatulence..) and withdrawal of the consent.
boolean
C0879626 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0021747 (UMLS CUI [1,3])
C0011581 (UMLS CUI [2,1])
C1706089 (UMLS CUI [2,2])
C0443146 (UMLS CUI [3])
C0040147 (UMLS CUI [4])
C0002874 (UMLS CUI [5])
C0879626 (UMLS CUI [6,1])
C0205082 (UMLS CUI [6,2])
C0035525 (UMLS CUI [6,3])
C0019054 (UMLS CUI [7,1])
C1706089 (UMLS CUI [7,2])
C1744706 (UMLS CUI [8,1])
C0076275 (UMLS CUI [8,2])
C1744706 (UMLS CUI [9,1])
C1696465 (UMLS CUI [9,2])
C1527304 (UMLS CUI [10])
C0011991 (UMLS CUI [11])
C0016204 (UMLS CUI [12])
C0021430 (UMLS CUI [13,1])
C2349954 (UMLS CUI [13,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video